Patents by Inventor Marielle Chiron

Marielle Chiron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination comprising combretastatin and anticancer agents
    Patent number: 7851443
    Abstract: This invention relates to therapeutic combinations comprising VEGF Trap and a stilbene derivative, and to methods for treatment of cancer comprising administration of such combinations.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: December 14, 2010
    Assignee: Aventis Pharma SA
    Inventors: Marie-Christine Bissery, Patricia Vrignaud, Marielle Chiron-Blondel, Brigitte Demers
  • ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN
    Publication number: 20100160233
    Abstract: Disclosed are antitumor combinations of VEGF inhibitors with Irinotecan and the use thereof in the treatment of neoplastic diseases.
    Type: Application
    Filed: January 4, 2010
    Publication date: June 24, 2010
    Applicant: Aventis Pharma S.A.
    Inventors: Marie-Christine BISSERY, Marielle CHIRON-BLONDEL, Pascale LEJEUNE, Patricia VRIGNAUD
  • ANTITUMOR COMBINATIONS CONTAINING A VEGF-INHIBITING AGENT AND 5FU OR A DERIVATIVE THEREOF
    Publication number: 20090285841
    Abstract: This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
    Type: Application
    Filed: July 24, 2009
    Publication date: November 19, 2009
    Applicants: AVENTIS PHARMA SA, REGENERON PHARMACEUTICALS INC.
    Inventors: Patricia VRIGNAUD, Marielle CHIRON-BLONDEL, Marie-Christine BISSERY, Eric FURFINE, Jocelyn HOLASH, Jesse M. CEDARBAUM
  • Combination Comprising Combretastatin and Anticancer Agents
    Publication number: 20090023656
    Abstract: This invention relates to therapeutic combinations comprising VEGF Trap and a stilbene derivative, and to methods for treatment of cancer comprising administration of such combinations.
    Type: Application
    Filed: June 19, 2008
    Publication date: January 22, 2009
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Marie-Christine BISSERY, Patricia VRIGNAUD, Marielle CHIRON-BLONDEL, Brigitte DEMERS
  • Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
    Publication number: 20060178305
    Abstract: This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
    Type: Application
    Filed: December 2, 2005
    Publication date: August 10, 2006
    Applicant: Aventis Pharma S.A.
    Inventors: Patricia Vrignaud, Marielle Chiron-Blondel, Marie-Christine Bissery, Eric Furfine, Jocelyn Holash, Jesse Cedarbaum
  • Compounds derived from oxindoles and their therapeutic application in cancer treatment
    Patent number: 6930124
    Abstract: The invention relates to compounds of formula (I) in which R5 is chosen from the group consisting of: in which R2 is a C1-C3 alkyl group in which X may be Cl, Br, or F in which n is between 1 and 3, in the E or Z form, or a mixture of the two isomeric forms, possessing antimitotic, antiproliferative and antivascular properties through inhibition of the polymerization of tubulin into microtubules
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: August 16, 2005
    Assignee: Aventis Pharma S. A.
    Inventors: Cécile Combeau, Patrick Mailliet, Marielle Chiron
  • Compounds derived from oxindoles and their therapeutic application in cancer treatment
    Publication number: 20040082645
    Abstract: The invention relates to compounds of formula (I) 1
    Type: Application
    Filed: September 10, 2003
    Publication date: April 29, 2004
    Inventors: Cecile Combeau, Patrick Mailliet, Marielle Chiron
  • Novel use of compounds of the chalcones class
    Publication number: 20020143064
    Abstract: Process for inhibiting vascularization of a tumor mass comprising administering, in an amount effective to inhibit vascularization, at least one chalcone of formula (I): 1
    Type: Application
    Filed: December 13, 2001
    Publication date: October 3, 2002
    Inventors: Marielle Chiron, Cecile Combeau, Patrick Mailliet